Olema Pharmaceuticals (OLMA) Net Equity Issued and Repurchased (2020 - 2024)

Olema Pharmaceuticals (OLMA) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $14.9 million in Q2 2024.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $14.9 million in Q2 2024; TTM through Jun 2024 was $57.8 million, a N/A change from a year earlier, with the FY2024 full-year figure at $22.8 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q2 2024 stood at $14.9 million, up from $7.9 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for OLMA reached as high as $36.7 million in Q3 2020 and fell as low as -$1.7 million in Q4 2020.